Please enable Javascript to use all features and improve your user experience.
WCNR 2024
Programme
Posters
People
Search
EN
Posters on the topic "Parkinson‘s disease"
Back
P-321
Practice approaches of physical therapists in managing psychosocial problems in people with Parkinson's disease
Adetayo Babarinde (Las Vegas, NV / US)
P-322
Physical therapists' understanding of psychosocial problems in people with Parkinson's disease
Adetayo Babarinde (Las Vegas, NV / US)
P-323
Effect of an intensive, structured, and progressive physiotherapy intervention on PD patients – a pilot study
Mrs Archana Ranade (Pune / IN)
P-324
Temporal coordination of head, trunk, and feet during 360-degree turning in Parkinson's disease
Pablo Burgos (Portland, OR / US; Santiago / CL)
P-325
Use of Metronome as auditory cue to promote chewing in oral dysphagia in Parkinson's disease: a case study
Tanvi Sanghavi (Mysuru / IN)
P-326
Cognitive flexibility training can improve postural function in people with Parkinson's disease
Arun Singh (Vermillion, SD / US)
P-327
Domain-specific and global changes in King's Parkinson's Pain Scale (KPPS) after Transcranial Direct Current Stimulation (TDCS) over M1 in Parkinson's disease patients
Professor Yeray González Zamorano (Madrid / ES)
P-328
Effects of transcranial direct current stimulation (tDCS) on pain modulation in individuals with parkinson's disease (PD) in "Off" state: a crossover pilot study
Professor Yeray González Zamorano (Madrid / ES)
P-329
Comparison of cognitive orientation to daily occupational performance and conventional occupational therapy in Parkinson's disease: a randomized clinical trial
Atefeh Taheri (Tehran / IR)
P-330
Prevalence of non-motor symptoms in Brazilians with Parkinson's disease
Dr Filipe Lopes (Belo Horizonte / BR)
P-331
Metric properties of inertial sensor-derived measures during the execution of UPDRS motor items in subjects with Parkinson disease: a systematic review
Dr Giulio Cherubini (Florence / IT)
P-333
The protective role of cardio-respiratory fitness in Parkinson's disease
Jacopo Cristini (Montreal / CA)
P-334
Exploring the influence of reaction time on postural stability among patients with Parkinson's disease: a cross-sectional study
Dr Jagadeesh Anbalagan (Kasaragod / IN; Coimbatore / IN)
P-335
Motor effects of combining bilateral repetitive transcranial magnetic stimulation and EEG-guided neurofeedback in Parkinson's disease: a pilot randomized, four-arm controlled trial
Dr Juan Pablo Romero Muñoz (Madrid / ES)
Professor Marcos Moreno Verdú (Brussels / BE; Madrid / ES)
P-336
Investigation of deviations in aging trajectories across difference brain regions in Parkinson's disease
Dr Jun-Ding Zhu (Taipei / TW)
P-337
Monitoring patients with Parkinson's disease: translational validation of an approach based on smartwatches
Professor Karina Lebel (Sherbrooke / CA)
P-338
Digital measurement of ocular microtremor in Parkinson's disease: reliability and clinical validation evidence
Lisa Graham (Newcastle upon Tyne / GB; Gateshead / GB)
P-339
Physiotherapy after Subthalamic Nucleus Deep Brain Stimulation in patients with Parkinson's disease: a Delphi consensus study on safety and efficacy
Dr Matteo Guidetti (Milan / IT)
P-340
Neural correlates of balance in Parkinson's disease: a systematic review
Patrick Tait (Newcastle upon Tyne / GB)
P-341
The role of life-long exposure to stimulating activities in explaining the gap between brain changes and telerehabilitation response in Parkinson's disease
Dr Sara Isernia (Milan / IT)
P-342
Assessing patient recognition of symptoms and knowledge about Parkinson's disease at Hospital Canselor Tuanku Muhriz
Mrs Siti Hajar Mat Desa (Bandar Puncak Alam / MY)
P-343
Effects of an incremental gait training on a treadmill and a customized virtual reality rehabilitation protocol, first results from the VIRTREAD-PD study: a randomized controlled trial in persons with PD
Dr Stefano Doronzio (Florence / IT)
P-344
Dysphagia: the experience of people with Parkinson's disease
Waad Alolayan (Edmonton / CA)
P-367
NX210c peptide: a promising drug candidate for the treatment of Parkinson's disease
Sighild Lemarchant (Lyon / FR)
v1.20.0
© Conventus Congressmanagement & Marketing GmbH
Imprint
Privacy